Page 80 - Bse

RIL rights issue oversubscribed nearly 1.3 times with one day still to go

Reliance Industries Ltd's Rs 53,124 crore rights issue, which has already been oversubscribed, on Tuesday received further bids for 8.8 crore

No proposal before board now, says Voda Idea on Google picking stake in co

The clarification to the BSE by Vodafone Idea comes a day after reports that Alphabet Inc's Google is eyeing about 5% stake in the telecom company.

Reliance Industries' rights entitlement surges 14% a day before close

Units worth nearly Rs 150 crore changed hands on the NSE and another Rs 554 crore on the BSE.

Sun Pharma Q4 profit declines 37% to Rs 399 cr on one-time exceptional loss

The company had posted a net profit of Rs 635.88 crore in the same period previous fiscal, Sun Pharma said in a BSE filing

Avenue Supermarts now 11th most valued Indian firm by market capitalisation

At close of trade, the company's market capitalisation stood at Rs 1,58,902.37 crore on the BSE.

BSE, NSE slash listing fee for SMEs by 25% amid Covid-19 crisis

The fee rebate has been declared following Finance Minister Nirmala Sitharaman's several announcements to rescue the ailing MSME sector

GlaxoSmithKline Q4 consolidated net profit declines 6% to Rs 138 cr

The company had posted a net profit of Rs 146.81 crore for the same period previous fiscal, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

DMart owner hikes stake in India Cements to 19.9%, stock zooms 13%

Analysts say acquirer may have found the firm attractive at the valuation at which it was available at

Biocon's Q4 revenue hit by Covid-19 crisis, pre-tax profit declines 28%

The net profit for the period declined 42.2 per cent to Rs 123 crore on YoY basis, according to a BSE filing by the company

Kotak Bank profit before tax slips 10.6% at Rs 2,674 cr for March 2020 qtr

Profit down due to Covid provisioning and lower other income

Market Ahead, May 13: Top Factors That Could Guide Markets Today

Today, a total of 10 companies, including Maruti Suzuki India, MPhasis, and ABB are scheduled to announce their results

Jubilant Life inks non-exclusive licensing pact with Gilead for Remdesivir

The drug, which is an injectable, got emergency approval from the US drug regulator recently.

MCX offers chance to exit trading if crude oil price slips into negative

Asking members and clients to be extra cautious while dealing in crude oil, the exchange has said trading will be halted if the trading price falls to Re 1

BSE enables negative price trading in crude oil, testing on Monday

Exchange's BOLT Plus trading system has been modified to execute such trades, existing versions of the trading system will also support negative pricing

In a locked-down world, investment bankers ensuring the show goes on

Billion-dollar deals aplenty for right business

Market Ahead, April 16: Top Factors That Could Guide Markets Today

Tech giant Tata Consultancy Services is scheduled to release its March quarter numbers and analysts see some erosion in the company's revenue due to the nationwide lockdown

BSE, NSE to continue with shortened hours for commodity trading

The two exchanges made the decision after the extension of the nationwide lockdown till May 3.

Market Ahead, April 15: All You Need To Know Before The Opening Bell

Wipro is slated to announce its Q4 numbers later in the day and most brokerages expect the company's revenue growth to come in at the lower end of the guided range of 0-2 per cent

Market Ahead, April 13: Top factors that could guide markets this week

HDFC will be in focus in today's session after the People's Bank of China increased its stake in the lending major to 1.01 per cent

Coronavirus: BSE cautions market intermediaries against cyber attacks

Many organisations have switched to work-from-home, due to outbreak of the pandemic, with employees using mobile phones, tabs and personal laptops in order to maintain business continuity